Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Opus Genetics Announces Presentation of OPGX-LCA5 Gene Therapy Data at ARVO; 12 Month Phase 1/2 Results Support Potential to Restore to Meaningful Vision
Posted On Monday, May 05, 2025
Palvella Therapeutics to Ring the Nasdaq Opening Bell on May 12, 2025
Posted On Monday, May 05, 2025
Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden
Posted On Sunday, May 04, 2025
Endogenex Highlights 48-Week REGENT-1 Clinical Study Results at Digestive Disease Week 2025
Posted On Saturday, May 03, 2025
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, May 02, 2025
NurExone Expands European Engagement with Investor Events in Germany and Switzerland
Posted On Friday, May 02, 2025
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Posted On Friday, May 02, 2025
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
Posted On Friday, May 02, 2025
Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call
Posted On Friday, May 02, 2025
Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest
Posted On Friday, May 02, 2025
International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers
Posted On Friday, May 02, 2025
Konik Capital Partners, LLC, a division of T.R. Winston & Co., Announces Official Launch
Posted On Friday, May 02, 2025
Longeveron® to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025
Posted On Friday, May 02, 2025
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results
Posted On Friday, May 02, 2025
Repeat: EnteroBiotix to Present Results from Phase 1b trial in Liver Cirrhosis at EASL Congress 2025
Posted On Friday, May 02, 2025
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results
Posted On Friday, May 02, 2025
ALX Oncology to Report First Quarter 2025 Financial Results on May 8, 2025
Posted On Friday, May 02, 2025
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
Posted On Friday, May 02, 2025
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
Posted On Friday, May 02, 2025
Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business Highlights
Posted On Friday, May 02, 2025
Cartesian Therapeutics Announces New Employment Inducement Grants
Posted On Friday, May 02, 2025
Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025
Posted On Friday, May 02, 2025
Metagenomi to Present at Upcoming Scientific Meetings
Posted On Friday, May 02, 2025
Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration
Posted On Friday, May 02, 2025
EnteroBiotix to Present Results from Phase 1b trial in Liver Cirrhosis at EASL Congress 2025
Posted On Friday, May 02, 2025

Print